# A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

> **NCT01975129** · PHASE2 · COMPLETED · sponsor: **PepTonic Medical AB** · enrollment: 12 (actual)

## Conditions studied

- Vaginal Atrophy

## Interventions

- **DRUG:** Vagitocin

## Key facts

- **NCT ID:** NCT01975129
- **Lead sponsor:** PepTonic Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975129, "A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01975129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*